Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04353739 · ClinicalTrials.gov registry record · NA
Testing a Self-management Intervention in HIV+ Asian Pacific Americans
A NA study of Self-management, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT04353739: Recruiting NA study of Self-management, sponsored by University of California, Los Angeles.
NCT04353739 is a NA study of Self-management that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 236-participant average among 5 other Self-management trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04353739, a NA study of Self-management, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
HIV infection rates are on a rapid rise within Asian Pacific Americans (APA) communities, with 80% of new infects being men. The purpose of this study is to adapt and evaluate the feasibility of a 4-session, 4-week family-informed self-management intervention protocol to promote health among APA men with HIV (APAMHIV). Family-informed self-management is a promising intervention to assist APAMHIV in securing family support and promoting health, and hence help address HIV epidemics in this understudied population.
Primary Outcome
The Acceptability of Intervention Measure (AIM) is a 4-item implementation outcome measure of acceptability used to monitor and evaluate the success of implementation efforts. AIM uses a Response Scale that includes: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Higher scores indicate greater acceptability.
Conditions Studied
Interventions
- BEHAVIORAL Self-Management for HIV-positive Asian Pacific Americans
Study Locations (2)
California
- APAIT - Los Angeles
New York
- Chinese-American Planning Council., Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT04353739 shows while recruiting
NCT04353739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 236-participant average among 5 other Self-management trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Self-management appearing as the primary indexed condition, and to 1 intervention - of which Self-Management for HIV-positive Asian Pacific Americans is the first listed.
NCT04353739 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT04353739 about?
NCT04353739 is a clinical study titled "Testing a Self-management Intervention in HIV+ Asian Pacific Americans". HIV infection rates are on a rapid rise within Asian Pacific Americans (APA) communities, with 80% of new infects being men. The purpose of this study is to adapt and evaluate the feasibility of a 4-session, 4-week family-informed self-management intervention protocol to promote health among APA men...
What is the current status of trial NCT04353739?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-01. Estimated completion is 2027-06-30.
What conditions does trial NCT04353739 study?
This clinical trial studies the following conditions: Self-management.
What interventions are being tested in trial NCT04353739?
The interventions under investigation include: Self-Management for HIV-positive Asian Pacific Americans (BEHAVIORAL).
Who is sponsoring clinical trial NCT04353739?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04353739 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self-management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Partners4Pain & Wellbeing: A Randomized Trial of Community Supported Complementary and Integrative Health Self-management for Back Pain
RECRUITING · NA
-
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
RECRUITING · NA
-
TARDIS - Photo Elicitation and Intervention
COMPLETED · NA
-
Efficacy of a Self-advocacy Serious Game Intervention
ACTIVE NOT RECRUITING · Phase 2
-
Tailored Approaches to Reduce Distress and Improve Self-Management for Veterans With Diabetes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI